David Goltzman

Last updated
David Goltzman
OC FRSC FRCPC
Alma mater McGill University
Occupation(s) Physician
Professor
Researcher

David Goltzman is a Canadian endocrinologist, Professor of Medicine and Physiology, and A.G. Massabki Chair in Medicine at McGill University in Montreal, Quebec. [1] [2] [3] He has been the Director of the Centre for Bone and Periodontal Research and also holds the position of Senior Scientist at the McGill University Health Centre Research Institute in the Metabolic Disorders and Complications Program. [1] [4]

Contents

Biography

He obtained a Bachelor of Science in biochemistry from McGill University in 1966, followed by a Doctor of Medicine from that same institution in 1968., [5] graduating as the Holmes Gold Medalist. He obtained clinical training as a resident in Internal Medicine at Columbia University in New York, and clinical and research training in Endocrinology at Mass General Hospital in Boston.

He has been actively registered as a member of the Collège des médecins du Québec since 1968 in the specialty of endocrinology and metabolism. [5] [6] He obtained his Royal College of Physicians and Surgeons of Canada fellowship certification in Internal Medicine in March 1974.

He joined McGill University as assistant professor in 1975. From 1978 to 1983, he was associate professor in the Department of Medicine. [5] and became full professor. [5] in 1983. He then joined the Department of Physiology, and served as Chair of the Department of Physiology from 1988 to 1993. From 1994 to 2004,he was Chair of the Department of Medicine. [5] [1] He was also Physician-in-Chief at the Royal Victoria Hospital from 1994 to 1998 and of the McGill University Health Centre from 1998 to 2004. [5]

In June 1994 he was named the A.G. Massabki Chair in Medicine at McGill University. [2]

He has been Director of the Centre for Advanced Bone and Periodontal Research, as well as Director of the Calcium Research Laboratory, [1] and from 2004 lead the Canadian Multicentre Osteoporosis Study(CaMos).

Research

His research mostly focuses on the hormonal regulation of mineral and skeletal homeostasis, including the function of parathyroid hormone, parathyroid hormone-related protein, and vitamin D. [1] [4] He has also made major contributions to our understanding of osteoporosis. [1] [4] and other metabolic bone diseases.

Publications and scholarly activities

He has published over 400 scholarly articles and has delivered numerous prestigious lectureships including the John T Haddad Memorial Lecture of the University of Pennsylvania, Division of Endocrinology in 2004, the Distinguished Lecturer in Nutritional Sciences, Columbia University College of Physicians and Surgeons, New York in 2005, the 1st Samuel York Lecture, Dalhousie Medical School, Halifax, Nova Scotia in 2008, the Gerald D Aurbach Lecture of the US Endocrine Society in 2009, the Wood lecturer, University of Calgary, Calgary, Alberta, and the David Hawkins lecture, Memorial University, Newfoundland in 2012, and the Henry Friesen Award and Lecture of the Canadian Society for Clinical Investigation and the Royal College of Physicians and Surgeons of Canada in 2017. He presided over many scientific societies and was President of the American Society for Bone and Mineral Research in 1999-2000. He has also trained numerous students, residents and fellows.

Honours and awards

His contributions have been recognized by election to the American Society for Clinical Investigation in 1981, and election as a fellow of both the Royal Society of Canada in 1995 and the Canadian Academy of Health Sciences. [1] in 2005. He was named an officer of the Order of Canada. [1] in 2000 and received the Queen Elizabeth II Golden Jubilee Medal in 2002. He has also received an Honorary Professorship from Nanjing Medical University, as well as a Doctor Honoris Causa from the University of Athens. [1] He received the Lawrence G. Raisz Award (inaugural) of the American Society for Bone and Mineral Research (ASBMR) in 2010, the Gold Medal of the Hellenic Physiological Society (Greece) and the Lindy Fraser Memorial Award of Osteoporosis Canada in 2012, the CP Leblond Award of the Réseau de recherche en santé buccodentaire et osseuse of the Fonds de recherche du Quebec in 2014.

Related Research Articles

<span class="mw-page-title-main">Endocrinology</span> Branch of medicine dealing the endocrine system

Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. Specializations include behavioral endocrinology and comparative endocrinology.

<span class="mw-page-title-main">Parathyroid hormone</span> Mammalian protein found in humans

Parathyroid hormone (PTH), also called parathormone or parathyrin, is a peptide hormone secreted by the parathyroid glands that regulates the serum calcium concentration through its effects on bone, kidney, and intestine.

<span class="mw-page-title-main">Dafydd Williams</span> Canadian astronaut, physician and public speaker (born 1954)

Dafydd Rhys "David" Williams is a Canadian physician, public speaker, author and retired CSA astronaut. Williams was a mission specialist on two Space Shuttle missions. His first spaceflight, STS-90 in 1998, was a 16-day mission aboard Space Shuttle Columbia dedicated to neuroscience research. His second flight, STS-118 in August 2007, was flown by Space Shuttle Endeavour to the International Space Station. During that mission he performed three spacewalks, becoming the third Canadian to perform a spacewalk and setting a Canadian record for total number of spacewalks. These spacewalks combined for a total duration of 17 hours and 47 minutes.

<span class="mw-page-title-main">Parathyroid hormone-related protein</span> Mammalian protein

Parathyroid hormone-related protein (PTHrP) is a proteinaceous hormone and a member of the parathyroid hormone family secreted by mesenchymal stem cells. It is occasionally secreted by cancer cells. However, it also has normal functions in bone, teeth, vascular tissues and other tissues.

<span class="mw-page-title-main">Hyperparathyroidism</span> Increase in parathyroid hormone levels in the blood

Hyperparathyroidism is an increase in parathyroid hormone (PTH) levels in the blood. This occurs from a disorder either within the parathyroid glands or as response to external stimuli. Symptoms of hyperparathyroidism are caused by inappropriately normal or elevated blood calcium excreted from the bones and flowing into the blood stream in response to increased production of parathyroid hormone. In healthy people, when blood calcium levels are high, parathyroid hormone levels should be low. With long-standing hyperparathyroidism, the most common symptom is kidney stones. Other symptoms may include bone pain, weakness, depression, confusion, and increased urination. Both primary and secondary may result in osteoporosis.

<span class="mw-page-title-main">McGill University Faculty of Medicine and Health Sciences</span> Medical school in Montreal, Canada

The Faculty of Medicine and Health Sciences is one of the constituent faculties of McGill University. It was established in 1829 after the Montreal Medical Institution was incorporated into McGill College as the college's first faculty; it was the first medical faculty to be established in Canada. The Faculty awarded McGill's first degree, and Canada's first medical degree to William Leslie Logie in 1833.

Barry Innis Posner, is a Canadian physician, research scientist and Professor Emeritus in the Departments of Medicine and Anatomy & Cell Biology at McGill University, where he also managed the Polypeptide and Protein Hormone Laboratory.

The Kolling Institute is located in the grounds of the Royal North Shore Hospital in St Leonards, Sydney Australia. The institute, founded in 1920, is the oldest medical research institute in New South Wales.

Senile osteoporosis has been recently recognized as a geriatric syndrome with a particular pathophysiology. There are different classification of osteoporosis: primary, in which bone loss is a result of aging and secondary, in which bone loss occurs from various clinical and lifestyle factors. Primary, or involuntary osteoporosis, can further be classified into Type I or Type II. Type I refers to postmenopausal osteoporosis and is caused by the deficiency of estrogen. While senile osteoporosis is categorized as an involuntary, Type II, and primary osteoporosis, which affects both men and women over the age of 70 years. It is accompanied by vitamin D deficiency, body's failure to absorb calcium, and increased parathyroid hormone.

<span class="mw-page-title-main">George P. Chrousos</span>

George P. Chrousos is professor of Pediatrics and Endocrinology Emeritus and former chairman of the Department of Pediatrics at the Athens University Medical School, Greece. Earlier he was senior investigator, director of the Pediatric Endocrinology Section and Training Program, and chief of the Pediatric and Reproductive Endocrinology Branch of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). He is also clinical professor of Pediatrics, Physiology and Biophysics at Georgetown University Medical School and distinguished visiting scientist, NICHD, NIH. Dr. Chrousos was the first general director of the Foundation of Biomedical Research of the Academy of Athens (2001–2002). He holds the UNESCO Chair on Adolescent Health Care, while he held the 2011 John Kluge Chair in Technology and Society, Library of Congress, Washington, D.C.

The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established in 1977 to promote excellence in bone and mineral research and to facilitate the translation of that research into clinical practice. The ASBMR has a membership of nearly 4,000 physicians, basic research scientists, and clinical investigators from around the world.

Michel Chrétien is a Canadian medical researcher specializing in neuroendocrinology research at the Institut de recherches cliniques de Montréal, or Clinical Research Institute of Montreal, (IRCM). He is a younger brother of former Canadian prime minister, Jean Chrétien.

<span class="mw-page-title-main">David Saint-Jacques</span> Canadian astronaut (born 1970)

David Saint-Jacques is a Canadian astronaut with the Canadian Space Agency (CSA). He is also an astrophysicist, engineer, and a physician.

Abaloparatide, sold under the brand name Tymlos among others, is a parathyroid hormone-related protein (PTHrP) analog medication used to treat osteoporosis. It is an anabolic agent.

John Symonds Lyon Browne was an English-born Canadian physician.

Pavel Hamet is a doctor, researcher, editor, academic administrator and teacher in Quebec, Canada.

Hans H. Zingg is a Professor Emeritus in the Department of Pharmacology and Therapeutics and Wyeth-Ayerst Chair in Women's Health at McGill University in Montreal, Quebec, Canada.

Abida Sophie Jamal is a Canadian endocrinologist and former osteoporosis researcher who was at the centre of a scientific misconduct case in the mid-to-late 2010s. Jamal published a high-profile paper suggesting that the heart medication nitroglycerin was a treatment for osteoporosis, and was later demonstrated to have misrepresented her results. She received a lifetime ban from receiving funding from the Canadian Institutes of Health Research and was named directly in their disclosure report, becoming the first person mentioned by name by the institute for scientific misconduct. Jamal was later stripped of her medical license for two years, regaining it in a controversial 3–2 decision.

Thomas John "Jack" Martin FRACP FRCPA is an Australian pathologist, emeritus professor of medicine, physician and academic at University of Melbourne, and researcher who, in 1987, by leading a former team of researchers at the same university, discovered a proteinaceous hormone called parathyroid hormone-related protein (PTHrP). In September 2005, further research was conducted by the team of Dengshun Miao and David Goltzman at the Calcium Research Laboratory and Department of Medicine, Royal Victoria Hospital of the McGill University Health Centre, and others.

Richard Kremer FRCPC is a physician-scientist who specializes in Endocrinology and Laboratory Medicine. Kremer is professor of medicine at McGill University in Montreal, Quebec, Canada. He is also a Senior Scientist at the Research Institute of the McGill University Health Centre at its Centre for Translational Biology. Kremer is also Director of the Bone and Mineral Unit and Academic Director at the McGill University Health Centre. and past Co-Director of the Musculoskeletal Axis. Kremer is a full member of the Canadian Institutes of Health Research's (CIHR) College of Reviewers.

References

  1. 1 2 3 4 5 6 7 8 9 "David Goltzman". Division of Endocrinology & Metabolism. McGill University. Retrieved 7 February 2019.
  2. 1 2 "Named/Endowed Chair Appointments at McGill University". Office of the Provost and Vice-Principal (Academic). McGill University. Retrieved 7 February 2019.
  3. ↑ "Goltzman, David MD". McGill University Health Centre. McGill University Health Centre. Retrieved 7 February 2019.
  4. 1 2 3 "David Goltzman, MD". McGill University Health Centre. Research Institute of the McGill University Health Centre. Retrieved 7 February 2019.
  5. 1 2 3 4 5 6 "GOLTZMAN, David". SECRÉTARIAT AUX EMPLOIS SUPÉRIEURS. Gouvernement du Québec. Retrieved 7 February 2019.
  6. ↑ "Bottin des médecins : Goltzman, David (69093)". Collège des médecins du Québec. Collège des médecins du Québec. Retrieved 7 February 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.